XML 20 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues        
Total revenues $ 10,009,781 $ 9,235,171 $ 57,250,527 $ 23,436,361
Operating expenses        
Cost of sales and supportive services 1,620,510 896,537 17,157,508 3,021,145
Selling, general and administrative 4,822,591 5,999,761 18,228,786 14,660,828
Research and development 3,024,593 3,648,117 8,966,905 13,810,307
Total operating expenses 9,467,694 10,544,415 44,353,199 31,492,280
Operating income/(loss) 542,087 (1,309,244) 12,897,328 (8,055,919)
Other income, net 1,330,505 883,148 4,590,935 2,964,482
Income/(Loss) before income taxes 1,872,592 (426,096) 17,488,263 (5,091,437)
(Provision)/Benefit for income taxes (528,647) 33,030 (4,034,362) 904,638
Net and comprehensive income/(loss) $ 1,343,945 $ (393,066) $ 13,453,901 $ (4,186,799)
Basic income/(loss) per share (in dollars per share) $ 0.02 $ (0.01) $ 0.19 $ (0.06)
Diluted income/(loss) per share (in dollars per share) $ 0.02 $ (0.01) $ 0.19 $ (0.06)
Weighted average shares outstanding: basic (in shares) 71,368,585 71,084,735 71,191,019 71,453,397
Weighted average shares outstanding: diluted (in shares) 71,766,503 71,084,735 71,853,341 71,453,397
Product Sales and Supportive Services [Member]        
Revenues        
Total revenues $ 8,942,875 $ 7,958,289 $ 53,496,869 $ 14,924,058
Research and Development [Member]        
Revenues        
Total revenues $ 1,066,906 $ 1,276,882 $ 3,753,658 $ 8,512,303